We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 41-60 of 7,204 results
  1. Zonisamide attenuates pressure overload-induced myocardial hypertrophy in mice through proteasome inhibition

    Myocardial hypertrophy is a pathological thickening of the myocardium which ultimately results in heart failure. We previously reported that...

    Qian Wu, Wan-jie Liu, ... **-yong Yu in Acta Pharmacologica Sinica
    Article 14 December 2023
  2. Assessment of Native Myocardial T1 Map** for Early Detection of Anthracycline-Induced Cardiotoxicity in Patients with Cancer: a Systematic Review and Meta-analysis

    Anthracycline antibiotic is one of the most effective anti-tumor drugs used to manage certain types of breast cancers, lymphomas, and leukemias....

    Amira A. Mohamed, Layla Y. Elmancy, ... Zaid H. Maayah in Cardiovascular Toxicology
    Article Open access 03 May 2024
  3. Generation of 3D-Multicellular Human iPSC-Heart Organoids for the Noninvasive Assessment of Cardiac Fibrosis

    The lack of a precise noninvasive, clinical evaluation method for cardiac fibrosis hinders the development of successful treatments that can...
    Antonio Lucena-Cacace, Yu Tian, Yoshinori Yoshida in Experimental Models of Cardiovascular Diseases
    Protocol 2024
  4. Endothelial NOX5 overexpression induces changes in the cardiac gene profile: potential impact in myocardial infarction?

    Cardiovascular diseases and the ischemic heart disease specifically constitute the main cause of death worldwide. The ischemic heart disease may lead...

    Adriana Cortés, Javier Marqués, ... Guillermo Zalba in Journal of Physiology and Biochemistry
    Article Open access 11 August 2023
  5. Impact of atorvastatin on plasma and cardiac biomarkers of inflammation, oxidative stress, and fibrosis in a rat model of streptozotocin-induced diabetes

    Oxidative stress and fibrosis foster the development of cardiovascular disease (CVD) in diabetes. Atorvastatin protects against cardiovascular...

    Fadia Mayyas, Tala Al Gharram in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 29 October 2022
  6. Cyanidin prevents cardiomyocyte apoptosis in mice after myocardial infarction

    Myocardial infarction is a worldwide disease with high morbidity and mortality and a major cause of chronic heart failure, seriously affecting...

    Deng Gang, Ouyang Qing, ... ** Zhu in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 13 February 2024
  7. Fibrosis and expression of extracellular matrix proteins in human interventricular septum in aortic valve stenosis and regurgitation

    Valvular heart disease leads to ventricular pressure and/or volume overload. Pressure overload leads to fibrosis, which might regress with its...

    David Sedmera, Alena Kvasilova, ... Radka Kockova in Histochemistry and Cell Biology
    Article Open access 12 February 2024
  8. Senescent cardiomyocytes contribute to cardiac dysfunction following myocardial infarction

    Myocardial infarction is a leading cause of morbidity and mortality. While reperfusion is now standard therapy, pathological remodelling leading to...

    Rachael E. Redgrave, Emily Dookun, ... Gavin D. Richardson in npj Aging
    Article Open access 14 June 2023
  9. Atorvastatin-induced tolerogenic dendritic cells improve cardiac remodeling by suppressing TLR-4/NF-κB activation after myocardial infarction

    Objective

    Myocardial infarction (MI) caused by ischemic cardiomyocyte necrosis induces inflammatory responses that strongly affect ventricular...

    Qian Wang, Zhaoyang Chen, ... Jianbing Zhu in Inflammation Research
    Article 31 October 2022
  10. Dual genetic tracing reveals a unique fibroblast subpopulation modulating cardiac fibrosis

    After severe heart injury, fibroblasts are activated and proliferate excessively to form scarring, leading to decreased cardiac function and...

    Maoying Han, Zixin Liu, ... Bin Zhou in Nature Genetics
    Article 23 March 2023
  11. Tissue fibrosis induced by radiotherapy: current understanding of the molecular mechanisms, diagnosis and therapeutic advances

    Cancer remains the leading cause of death around the world. In cancer treatment, over 50% of cancer patients receive radiotherapy alone or in...

    Zuxiang Yu, Chaoyu Xu, ... Shuyu Zhang in Journal of Translational Medicine
    Article Open access 09 October 2023
  12. Thymoquinone dose-dependently attenuates myocardial injury induced by isoproterenol in rats via integrated modulations of oxidative stress, inflammation, apoptosis, autophagy, and fibrosis

    As rats develop myocardial infarction (MI) like lesions when injected with large doses of isoproterenol (ISO), this investigation was designed to...

    Mahmoud M. Farag, Asmaa A. Khalifa, ... Radwa M. Rashad in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 03 July 2021
  13. Exosomes From Human Umbilical Cord Stem Cells Suppress Macrophage-to-myofibroblast Transition, Alleviating Renal Fibrosis

    Renal fibrosis, a progressive scarring of the kidney, lacks effective treatment. Human umbilical cord mesenchymal stem cell-derived exosomes...

    Qitong Guo, ** Li, ... Deying Zhang in Inflammation
    Article 25 April 2024
  14. Genome Editing and Myocardial Development

    Congenital heart disease (CHD) has a strong genetic etiology, making it a likely candidate for therapeutic intervention using genetic editing....
    Sifa Turan, J. Richard Chaillet, ... Yijen L. Wu in Genome Editing in Cardiovascular and Metabolic Diseases
    Chapter 2023
  15. Activating α7nAChR helps post-myocardial infarction healing by regulating macrophage polarization via the STAT3 signaling pathway

    Background

    Monocytes/macrophages play critical roles in inflammation and cardiac remodeling following myocardial infarction (MI). The cholinergic...

    **ao-Hui Niu, Rong-Hua Liu, ... Jia-Feng Lin in Inflammation Research
    Article 13 March 2023
  16. A novel treatment for heart failure targets myocardial fibrosis

    John G. F. Cleland, Pierpaolo Pellicori, Arantxa González in Nature Medicine
    Article 12 August 2021
  17. Inhalation Lenalidomide-Loaded Liposome for Bleomycin-Induced Pulmonary Fibrosis Improvement

    Idiopathic pulmonary fibrosis (IPF) is a progressive, fibrotic interstitial lung disease with unclear etiology and increasing prevalence. Pulmonary...

    Zhilin Luo, Liyuan Ji, ... Cheng Yang in AAPS PharmSciTech
    Article 16 November 2023
  18. IL-1 signaling pathway, an important target for inflammation surrounding in myocardial infarction

    Acute myocardial infarction is an important cardiovascular disease worldwide. Although the mortality rate of myocardial infarction (MI) has improved...

    Jianwu Huang, Wenlong Kuang, Zihua Zhou in Inflammopharmacology
    Article 27 April 2024
  19. Macrophage and fibroblast trajectory inference and crosstalk analysis during myocardial infarction using integrated single-cell transcriptomic datasets

    Background

    Cardiac fibrosis after myocardial infarction (MI) has been considered an important part of cardiac pathological remodeling. Immune cells,...

    Da Ke, Mingzhen Cao, ... Heng Zhou in Journal of Translational Medicine
    Article Open access 12 June 2024
  20. YAP1 inhibits the senescence of alveolar epithelial cells by targeting Prdx3 to alleviate pulmonary fibrosis

    The senescence of alveolar type II (AT2) cells impedes self-repair of the lung epithelium and contributes to lung injury in the setting of idiopathic...

    Wei Su, Yingying Guo, ... Haihai Liang in Experimental & Molecular Medicine
    Article Open access 01 July 2024
Did you find what you were looking for? Share feedback.